Prophylthiouracil-induced diffuse proliferative lupus nephritis: Review of immunological complications

Journal of the American Society of Nephrology

Volumn 8, Issue 7, 1997, Pages 1205-1210

  Ramesh Prasad, G V ^a   Bastacky, Sheldon ^a   Johnson, John P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; ANTITHYROID AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; FEMALE; GRAVES DISEASE; HUMAN; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; ANTIGEN ANTIBODY COMPLEX; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; REVIEW;

ADULT; ANTIGEN-ANTIBODY COMPLEX; ANTITHYROID AGENTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GRAVES DISEASE; HUMANS; KIDNEY; LUPUS NEPHRITIS; PROPYLTHIOURACIL;

EID: 0031182795     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Schur PH: Clinical features of SLE. In: Textbook of Rheumatology, 4th Ed., edited by Kelley WN, Harris ED, Ruddy S, Sledge CB, Philadelphia, W. B. Saunders, 1993, pp 1017-1042
2. Amrhein JA, Kenny FM. Ross D: Granulocytopenia, lupus-like syndrome and other complications of propylthiouracil therapy. J Pediatr 76: 54-63, 1970
3. Best MM, Duncan CH: A lupus-like syndrome following propylthiouracil administration. J Kentucky Med Assoc 62: 47-49, 1964
4. Berkman EM, Orlin JB, Wolfsdorf J: An antineutrophil antibody associated with a propylthiouracil induced lupus-like syndrome. Transfusion 23: 135-138, 1993
5. Tsokos GC: Immunologic aspects in humans. Ann Intern Med 106: 79-94, 1987
6. Rubin RL, Bell SA, Burlingame RW: Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest 90: 165-173, 1992
7. Wing SS, Fantus IG: Adverse immunologic effects of antithyroid drugs. Can Med Assoc J 136: 121-127, 1987
8. Shabtai R, Shapiro MS, Orenstein D, Taragan R, Shenkman L: The antithyroid arthritis syndrome reviewed. Arthritis Rheum 27: 227-229, 1984
9. Griswold WR, Mendoza SA, Johnston W, Nichols S: Vasculitis associated with propylthiouracil. West J Med 128: 543-546, 1978
10. Reidy TJ, Upshaw JD, McCChesney T: Propylthiouracil-induced vasculitis: A fatal case. South Med J 75: 1297-1298, 1992
11. D'cruz D, Chesser AMS, Lightowler C, Comer M, Hurst MJ, Baker LRI, Raine AEG: Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34: 1090-1091, 1995
12. Dolman KM, Gans R, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, Donker AJ, von dem Borne AE, Goldschmeding R: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342: 651-652, 1993
13. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A: Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124: 986-988, 1994
14. Cassorla FG, Finegold DN, Parks JS, Tenore A, Thawerani H, Baker L: Vasculitis, pulmonary cavitation and anemia during antithyroid drug therapy. Am J Dis Child 137: 118-122, 1983
15. Reinhart SC, Moses AM, Cleary L, Scheinman SJ: Acute interstitial nephritis with renal failure associated with propylthiouracil therapy. Am J Kidney Dis 24: 575-577, 1994
16. Lee SL, Chase PH: Drug-induced systemic lupus erythematosus: A critical review. Semin Arthritis Rheum 5: 83-103, 1975
17. Fu LS, Yang LY, Chen WP, Chao T, Ooi SK, Lin CY: Class IV lupus nephritis associated with Graves' disease. Child Nephrol Urol 12: 51-54, 1992
18. Steinberg AD, Steinberg SC: Long term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34: 945-950, 1991